We maintain full compliance with DRAP (Drug Regulatory Authority of Pakistan) and international regulatory bodies, ensuring every product and study meets the highest legal and ethical standards. Our regulatory team has successfully filed over 80 drug submissions with a 95%+ approval rate.

From AI-assisted drug discovery to advanced biologics formulation, our R&D teams constantly push the boundaries of what is possible in pharmaceutical science. We hold multiple patents for novel drug delivery systems tailored for tropical and endemic disease conditions.

Over 17 years of demonstrated excellence in pharmaceutical services, drug development, and clinical research. Our portfolio includes successful market authorizations for 200+ drug products and the completion of 50+ clinical studies across diverse therapeutic areas.

Our multidisciplinary team includes board-certified pharmacists, clinical investigators, regulatory scientists, and pharmaceutical chemists with degrees from leading global institutions. Continuous professional development ensures our team stays at the cutting edge.

Uniquely positioned at the intersection of global pharmaceutical best practices and deep understanding of Pakistan's healthcare ecosystem. We operate to ICH, WHO, and FDA comparable standards while navigating local market realities with finesse.

Every decision we make is grounded in one question: does this benefit patients? This philosophy drives our commitment to affordable drug access, safe formulations, and clinically meaningful research that addresses the disease burden faced by Pakistani populations.

We employ best-in-class data management systems and clinical data governance frameworks. All clinical trial data is handled with strict GCP compliance, electronic audit trails, and independent data monitoring committees to ensure the highest integrity standards.

Whether you are a startup biotech looking for CRO support or a multinational seeking a local partnership, our infrastructure scales to match your needs. We offer flexible engagement models from full-service to functional service provider arrangements.